MwanzoOPL • ASX
add
Opyl Ltd
Bei iliyotangulia
$ 0.018
Bei za mwaka
$ 0.014 - $ 0.042
Thamani ya kampuni katika soko
3.07M AUD
Wastani wa hisa zilizouzwa
elfu 66.80
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
ASX
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (AUD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 76.98 | -53.11% |
Matumizi ya uendeshaji wa biashara | elfu 421.40 | 55.20% |
Mapato halisi | elfu -927.04 | -67.65% |
Kiwango cha faida halisi | elfu -1.20 | -257.51% |
Mapato kwa kila hisa | — | — |
EBITDA | elfu -909.06 | -66.48% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (AUD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | elfu 374.64 | -17.27% |
Jumla ya mali | elfu 411.60 | -41.99% |
Jumla ya dhima | elfu 501.76 | -54.93% |
Jumla ya hisa | elfu -90.16 | — |
hisa zilizosalia | 222.15M | — |
Uwiano wa bei na thamani | ∞ | — |
Faida inayotokana na mali | -556.44% | — |
Faida inayotokana mtaji | 2,540.24% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (AUD) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | elfu -927.04 | -67.65% |
Pesa kutokana na shughuli | elfu -738.29 | -58.54% |
Pesa kutokana na uwekezaji | elfu -8.86 | -7,807.14% |
Pesa kutokana na ufadhili | elfu 642.12 | 72.83% |
Mabadiliko halisi ya pesa taslimu | elfu -105.03 | -11.42% |
Mtiririko huru wa pesa | elfu -171.58 | 42.93% |
Kuhusu
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
Ilianzishwa
2013
Tovuti
Wafanyakazi
3
